These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2147192)

  • 1. Comparison of panic disordered patients with high versus low MHPG.
    Garvey M; Noyes R; Cook B
    J Affect Disord; 1990 Sep; 20(1):7-12. PubMed ID: 2147192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevations of urinary MHPG in depressed patients with panic attacks.
    Garvey MJ; Tollefson GD; Orsulak PJ
    Psychiatry Res; 1987 Mar; 20(3):183-7. PubMed ID: 3588779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
    Garvey M; Noyes R; Cook B; Tollefson G
    Psychiatry Res; 1989 Oct; 30(1):53-61. PubMed ID: 2594871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
    Eriksson E; Westberg P; Alling C; Thuresson K; Modigh K
    Psychiatry Res; 1991 Mar; 36(3):243-51. PubMed ID: 1712114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Situational panic attacks. Behavioral, physiologic, and biochemical characterization.
    Woods SW; Charney DS; McPherson CA; Gradman AH; Heninger GR
    Arch Gen Psychiatry; 1987 Apr; 44(4):365-75. PubMed ID: 2882735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications.
    Uhde TW; Joffe RT; Jimerson DC; Post RM
    Biol Psychiatry; 1988 Mar; 23(6):575-85. PubMed ID: 2833321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS; Heninger GR; Breier A
    Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low MHPG and continuing treatment in panic disorder.
    Edlund MJ; Swann AC
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):701-7. PubMed ID: 2781042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls.
    Gurguis GN; Uhde TW
    Psychoneuroendocrinology; 1990; 15(3):217-24. PubMed ID: 2255749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma MHPG levels in lactate and isoproterenol anxiety states.
    Pohl R; Ettedgui E; Bridges M; Lycaki H; Jimerson D; Kopin I; Rainey JM
    Biol Psychiatry; 1987 Sep; 22(9):1127-36. PubMed ID: 3651531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.
    Charney DS; Heninger GR
    Arch Gen Psychiatry; 1985 May; 42(5):473-81. PubMed ID: 2985014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma MHPG in untreated panic disorder.
    Edlund MJ; Swann AC; Davis CM
    Biol Psychiatry; 1987 Dec; 22(12):1491-5. PubMed ID: 3676379
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperventilation: is it a cause of panic attacks?
    Hibbert G; Pilsbury D
    Br J Psychiatry; 1989 Dec; 155():805-9. PubMed ID: 2515911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia.
    Kathol RG; Noyes R; Lopez AL; Reich JH
    Psychiatry Res; 1988 May; 24(2):211-21. PubMed ID: 3406239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased anxiogenic effects of caffeine in panic disorders.
    Charney DS; Heninger GR; Jatlow PI
    Arch Gen Psychiatry; 1985 Mar; 42(3):233-43. PubMed ID: 2983630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual fluctuation in the symptoms of panic anxiety.
    Cameron OG; Kuttesch D; McPhee K; Curtis GC
    J Affect Disord; 1988; 15(2):169-74. PubMed ID: 2975688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Biol Psychiatry; 1992 Jul; 32(1):18-25. PubMed ID: 1391293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saliva level of free 3-methoxy-4-hydroxyphenylglycol (MHPG) as a biological index of anxiety disorders.
    Yamada S; Yamauchi K; Yajima J; Hisadomi S; Maeda H; Toyomasu K; Tanaka M
    Psychiatry Res; 2000 Apr; 93(3):217-23. PubMed ID: 10760380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.